EASYMYTRIP BUY Investment Update
Recommendation: Buy the script as it presents a favorable opportunity for upside potential.
Upside Potential: Expecting a 16–20% rise within the next 1–2 months.
Target Levels:
Initial Target: ₹18
Secondary Target: ₹21
Stop-Loss (SL): Place a stop-loss at ₹15 to manage risk effectively.
Rationale: Despite its recent underperformance, the script belongs to a fundamentally strong company and is poised for a rebound.